Status:
RECRUITING
Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes Mellitus
Lead Sponsor:
University of Sao Paulo
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
IntroductionType 1 Diabetes Mellitus (T1DM) requires lifelong exogenous insulin therapy, along with self-management strategies, such as carbohydrate counting, to appropriately adjust insulin doses in ...
Eligibility Criteria
Inclusion
- Diagnosis of type 1 diabetes mellitus
- children between 6 and 18 years old and their caregivers; and adults \> 18 years old.
- Glycated Hb between 7.2-10.5% in the last 6 months. Being on a basal-bolus regimen Participating in and understanding the guidelines on how to use the program to be tested in this study Agreeing to the free and informed consent form. Performing periodic monitoring at the DM outpatient clinic at HC-FMUSP
Exclusion
- Not understanding the instructions.
- Being illiterate
- Not attending the visits proposed by the study
- Not using the tool via WhatsApp.
- Not accepting consent.
- Interacting with the tool less than 3 days a week during the study period.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07150052
Start Date
May 1 2025
End Date
December 1 2026
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo
São Paulo, São Paulo, Brazil, 04026-001